Literature DB >> 34623210

Health Care Use and Outcomes in Assisted Living Communities: Race, Ethnicity, and Dual Eligibility.

Helena Temkin-Greener1, Yunjiao Mao1, Brian McGarry1, Sheryl Zimmerman2, Yue Li1.   

Abstract

Assisted Living (AL) has become an important residential long-term care option in the United States, yet very little is known about the nature and quality of care received in this setting by racial/ethnic minorities or residents dually eligible for Medicare and Medicaid. Using calendar year 2018 Medicare data, we identified 255,564 fee-for-service Medicare beneficiaries age 55+ who resided in 24,108 ALs across the United States. We fit several logistic regression models with individual-level covariates and AL-level fixed effects, to examine the association between race/ethnicity and dual status with inpatient hospital admission, 30-day readmission, emergency room use, and nursing home placement. Significant variations in these measures were found both within and across ALs for racial/ethnic minority and dual residents. Our results suggest that disparities in outcomes are most significant by dual eligibility status rather than by race/ethnicity alone. These findings provide important implications for providers, policy makers, and researchers.

Entities:  

Keywords:  Assisted Living; disparities; duals; race/ethnicity

Mesh:

Year:  2021        PMID: 34623210      PMCID: PMC8989767          DOI: 10.1177/10775587211050189

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   2.971


  2 in total

1.  Using Medicare Enrollment Data to Identify Beneficiaries in Assisted Living.

Authors:  Helena Temkin-Greener; Yunjiao Mao; Yue Li; Brian McGarry
Journal:  J Am Med Dir Assoc       Date:  2022-02-20       Impact factor: 7.802

2.  Post-acute care transitions and outcomes among medicare beneficiaries in assisted living communities.

Authors:  Jinjiao Wang; Yunjiao Mao; Brian McGarry; Helena Temkin-Greener
Journal:  J Am Geriatr Soc       Date:  2022-01-25       Impact factor: 7.538

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.